Alfonso Berrocal

Alfonso Berrocal

UNVERIFIED PROFILE

Are you Alfonso Berrocal?   Register this Author

Register author
Alfonso Berrocal

Alfonso Berrocal

Publications by authors named "Alfonso Berrocal"

Are you Alfonso Berrocal?   Register this Author

21Publications

673Reads

49Profile Views

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study.

Melanoma Res 2016 06;26(3):278-83

aMedical Oncology Service, Hospital Universitario La Paz bMedical Oncology Service, Hospital Ramón y Cajal cMedical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañon dMedical Oncology Service, Hospital La Princesa eMedical Affairs, Merck Sharp & Dohme, Madrid fMedical Oncology Service, Instituto Valenciano de Oncología gMedical Oncology Service, Hospital General Universitario de Valencia hMedical Oncology Service, Hospital La Fe, Valencia iMedical Oncology Service, Hospital Clinic de Barcelona, Barcelona jMedical Oncology Service, Hospital de Basurto, Bilbao kMedical Oncology Service, Hospital Teresa Herrera, La Coruña lMedical Oncology Service, Hospital Central de Asturias, Oviedo mMedical Oncology Service, Hospital General Universitario Santa Lucía, Cartagena nMedical Oncology Service, Hospital de Cruces, San Vicente de Baracaldo oMedical Oncology Service, Hospital Universitario Virgen de la Victoria, Málaga pDermatology Service, Complejo Asistencial Universitario de León, León qMedical Oncology Service, Hospital Miguel Servet, Zaragoza rMedical Oncology Service, Hospital Virgen de la Macarena, Sevilla sMedical Oncology Service, Hospital Clínico Universitario de Valladolid, Valladolid tMedical Oncology Service, Hospital Clínico Universitario de Santiago, Santiago de Compostela uMedical Oncology Service, Clínica Universitaria de Navarra, Pamplona, Spain vGlobal Health Outcomes Research, Merck Sharp & Dohme, Kenilworth, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000254DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861701PMC
June 2016

Immune checkpoint inhibitors: therapeutic advances in melanoma.

Ann Transl Med 2015 Oct;3(18):267

1 Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañon, Madrid, Spain ; 2 Spanish Melanoma Group (GEM); 3 Servicio Oncología Médica, Hospital General Universitario Santa Lucía, Cartagena, Spain ; 4 Servicio de Oncología Médica, Universitario Ramon y Cajal, Madrid, Spain ; 5 Servicio de Oncología Médica, Hospital General Universitario de Valencia, Valencia, Spain ; 6 Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona, Spain ; 7 Servicio de Oncología Médica, Clínica Universitaria de Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2305-5839.2015.10.27DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630549PMC
October 2015

Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.

Nat Med 2015 Jul 1;21(7):741-50. Epub 2015 Jun 1.

1] Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain. [2] Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain. [3] Institucio Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.3863DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968631PMC
July 2015

Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program.

Melanoma Res 2014 Dec;24(6):577-83

aMedical Oncology, Hospital General Valencia bMedical Oncology, Instituto Valenciano de Oncologia, Valencia cMedical Oncology, Hospital Clinic i Provincial dMedical Oncology, Hospital Vall d´Hebron, Barcelona eMedical Oncology, Hospital 12 de Octubre fMedical Oncology, Hospital La Paz gMedical Oncology, Hospital MD Anderson Cancer Center, Madrid hMedical Oncology, Hospital ClinicoVirgen de la Victoria, Malaga iMedical Oncology, Hospital Virgen de las Nieves, Granada jMedical Oncology, Clinica Universitaria de Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457498PMC
December 2014

SEOM guideline for the treatment of malignant glioma.

Clin Transl Oncol 2012 Jul;14(7):545-50

Medical Oncology Service, Hospital General Universitario, Valencia, Spain.

View Article

Download full-text PDF

Source
July 2012

Advances in cutaneous melanoma.

Clin Transl Oncol 2012 May;14(5):325-32

Service of Oncology, Hospital La Paz, Madrid, Spain.

View Article

Download full-text PDF

Source
May 2012

Oncology outside hospital: a new experience for the benefit of longer survivors.

Clin Transl Oncol 2011 Apr;13(4):249-53

Medical Oncology Department, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-011-0649-2DOI Listing
April 2011

Analysis of c-kit expression in small cell lung cancer: prevalence and prognostic implications.

Lung Cancer 2006 Jun 30;52(3):343-7. Epub 2006 Mar 30.

Servicio de Oncología Médica, Consorcio Hospital General Universitario de Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2006.02.003DOI Listing
June 2006

Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients: efficacy and tolerability.

Anticancer Res 2005 Nov-Dec;25(6C):4611-4

Servicio de Oncologáa Médica, Hospital General Universitario de Valencia, Spain.

View Article

Download full-text PDF

Source
January 2006